Vol. 3 No. 1 | January 2012

Vol. 3 No. 1 | January 2012

ISBN: 2150-7740

target articles

Building upon an earlier critique of the Food and Drug Adminstration (FDA) granting of a humanitarian device exemption for deep brain stimulation in treatment-resistant obsessive compulsive disorder, this article considers how we regulate and finance DBS. It suggests that these devices are mosaic in nature: both potentially therapeutic and probative and that their dual roles need to be appreciated...

Click for More